Published in Br J Cancer on October 31, 2005
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res (2007) 3.97
Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68
Breast cancer - one term, many entities? J Clin Invest (2011) 1.72
Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. J Natl Cancer Inst (2010) 1.55
Tumor Lysis Syndrome in Solid Tumors: An up to Date Review of the Literature. Rare Tumors (2014) 1.48
Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat (2011) 1.45
Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer (2009) 1.37
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat (2007) 1.31
Histological, molecular and functional subtypes of breast cancers. Cancer Biol Ther (2010) 1.30
Clinical management of breast cancer heterogeneity. Nat Rev Clin Oncol (2015) 1.22
Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol (2008) 1.17
Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res (2010) 1.02
Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified. J Korean Med Sci (2010) 1.01
Unusual aggressive breast cancer: metastatic malignant phyllodes tumor. J Radiol Case Rep (2013) 0.99
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype. Eur J Nucl Med Mol Imaging (2015) 0.98
Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004. Breast Cancer Res (2007) 0.96
Late age at first full term birth is strongly associated with lobular breast cancer. Cancer (2010) 0.95
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma. J Nucl Med (2015) 0.94
Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer (2010) 0.94
Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer. PLoS One (2013) 0.93
Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D. Pharmacognosy Res (2015) 0.91
Illuminating breast cancer invasion: diverse roles for cell-cell interactions. Curr Opin Cell Biol (2014) 0.91
Microtubule-associated protein Mdp3 promotes breast cancer growth and metastasis. Theranostics (2014) 0.91
Breast cancer in systemic lupus erythematosus. Oncology (2013) 0.89
Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res (2015) 0.88
Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast. Breast Cancer Res Treat (2013) 0.87
Reproductive factors, age at maximum height, and risk of three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.87
Infiltrating lobular carcinoma of the breast presenting as gastrointestinal obstruction: a mini review. J Cancer (2012) 0.86
Invasive breast cancer: a significant correlation between histological types and molecular subgroups. J Cancer Res Clin Oncol (2012) 0.86
Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study. Medicine (Baltimore) (2015) 0.85
Expression of metalloproteases and their inhibitors in different histological types of breast cancer. J Cancer Res Clin Oncol (2009) 0.85
G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis. Mol Cancer Res (2014) 0.85
The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study. BMC Cancer (2010) 0.84
Management of unusual histological types of breast cancer. Oncologist (2012) 0.84
Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry. Breast Cancer Res Treat (2012) 0.84
Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. J Breast Cancer (2013) 0.83
Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database. Oncotarget (2016) 0.82
Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population. World J Surg Oncol (2012) 0.82
Absence of microsatellite instability in mucinous carcinomas of the breast. Int J Clin Exp Pathol (2010) 0.81
Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study. Am J Epidemiol (2013) 0.81
Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics. Am J Epidemiol (2014) 0.81
Clinicopathological characteristics and prognosis of mucinous breast carcinoma. J Cancer Res Clin Oncol (2013) 0.80
Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer. Ann Surg Oncol (2015) 0.80
Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study. Medicine (Baltimore) (2016) 0.78
Mucinous breast cancer - clinical characteristics and treatment results in patients treated at the Oncology Centre in Kraków between 1952 and 2002. Contemp Oncol (Pozn) (2014) 0.78
Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma. Yonsei Med J (2015) 0.77
Expression of autophagy related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma. Int J Clin Exp Pathol (2014) 0.77
Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction. PLoS One (2016) 0.76
[Lobular neoplasms and invasive lobular breast cancer]. Pathologe (2014) 0.76
Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population. PLoS One (2015) 0.76
Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment. Int J Breast Cancer (2016) 0.76
FDG PET/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer. Clin Nucl Med (2017) 0.75
Papillary carcinoma of breast: Minireview. World J Clin Cases (2016) 0.75
Invasive ductal carcinoma of the breast with osteoclast-like giant cells and clear cell features: a case report of a novel finding and review of the literature. World J Surg Oncol (2016) 0.75
Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma. Int J Mol Sci (2017) 0.75
Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study. PLoS One (2016) 0.75
New primary ipsilateral metachronous breast tumor: a case report. Case Rep Oncol (2012) 0.75
Molecular Classification of Lobular Carcinoma of the Breast. Sci Rep (2017) 0.75
Comparison of clinicopathological characteristics of lymph node positive and lymph node negative breast cancer. Pak J Med Sci (2016) 0.75
A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy: a case report. Cancer Res Treat (2007) 0.75
High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer. Oncol Lett (2017) 0.75
Relationship among mammographic findings with histopathologic type of breast cancer and human epidermal growth factor receptor 2 (HER2) in young women. Electron Physician (2017) 0.75
Alcohol Intake and Risk of Breast Cancer by Histologic Subtype and Estrogen Receptor Status Among Women Aged 55 to 74 Years. Horm Cancer (2017) 0.75
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res (2004) 3.90
Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol (2003) 3.27
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA (2003) 2.24
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer (1994) 2.06
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol (1992) 1.86
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (2000) 1.83
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev (2004) 1.72
Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 1.56
Hormone receptor status of breast cancer in India: a study of 798 tumours. Breast (2000) 1.43
Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med (2003) 1.36
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States). Cancer Causes Control (2003) 1.32
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer (2004) 1.22
Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev (2003) 1.13
Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg (1993) 1.09
A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat (2004) 1.09
Experience with lobular carcinoma of the breast. Emphasis on recent aspects of management. Arch Surg (1979) 1.06
Surveillance, epidemiology, and end results: incidence and mortality data, 1973-77. Natl Cancer Inst Monogr (1981) 1.00
Age distribution of histologic types of breast carcinoma. Int J Cancer (1993) 0.94
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Ovarian tumors in a cohort of infertile women. N Engl J Med (1994) 4.91
Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med (1997) 4.21
BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med (1996) 3.83
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91
Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med (1980) 2.86
Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst (2001) 2.73
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.58
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51
Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA (1995) 2.43
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst (1995) 2.36
Characteristics of women with and without breast augmentation. JAMA (1997) 2.26
Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol (2001) 2.18
Risk factors for sudden infant death syndrome: changes associated with sleep position recommendations. J Pediatr (2001) 2.09
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer (2005) 1.96
Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. J Natl Cancer Inst (2001) 1.95
Correlates of homosexual behavior and the incidence of anal cancer. JAMA (1982) 1.95
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res (2001) 1.89
Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer (2000) 1.83
Perinatal factors and risk of breast cancer. Epidemiology (1996) 1.82
Case-control differences in the reliability of reporting a history of induced abortion. Am J Epidemiol (2000) 1.82
Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer (1999) 1.82
Prenatal care and pregnancy outcomes during the recession: the Washington State experience. Am J Public Health (1985) 1.76
Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer (2000) 1.75
Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst (1987) 1.74
Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72
Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg (2001) 1.71
Infant mortality among subsequent siblings of infants who died of sudden infant death syndrome. J Pediatr (1986) 1.70
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Use of electric blankets and risk of testicular cancer. Am J Epidemiol (1990) 1.69
Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med (1985) 1.69
Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum (1993) 1.64
Recreational drug use and the risk of primary infertility. Epidemiology (1990) 1.64
Epidemiology of ectopic pregnancy. Epidemiol Rev (1987) 1.62
Induced abortion and subsequent outcome of pregnancy in a series of American women. N Engl J Med (1977) 1.56
Vasectomy and the incidence of testicular cancer. Am J Epidemiol (1988) 1.55
Induced abortion and subsequent outcome of pregnancy. A matched cohort study. Lancet (1975) 1.55
Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. Am J Epidemiol (1984) 1.54
Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Teratology (1995) 1.53
History of lactation and breast cancer risk. Am J Epidemiol (1993) 1.52
Risk of breast cancer in a cohort of infertile women. Gynecol Oncol (1996) 1.51
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer (1997) 1.50
Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite. J Clin Epidemiol (1989) 1.50
Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst (1995) 1.50
Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology (1995) 1.49
Pregnancy characteristics and maternal risk of breast cancer. Epidemiology (1998) 1.48
Incidence of thyroid cancer in women in relation to previous exposure to radiation therapy and history of thyroid disease. J Natl Cancer Inst (1984) 1.47
Changing incidence rate of invasive lobular breast carcinoma among older women. Cancer (2000) 1.45
Erb/Duchenne's palsy: a consequence of fetal macrosomia and method of delivery. Obstet Gynecol (1986) 1.43
Past use of an intrauterine device and risk of tubal pregnancy. Epidemiology (1993) 1.41
Validity and reliability of subject and mother reporting of perinatal factors. Am J Epidemiol (1998) 1.41
Control definition in case-control studies of ectopic pregnancy. Am J Public Health (1985) 1.40
Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol (1992) 1.40
Birth weight and the incidence of childhood cancer. J Natl Cancer Inst (1984) 1.39
Prostate cancer in relation to the use of electric blanket or heated water bed. Epidemiology (1999) 1.38
Measurement of urinary estrogen metabolites using a monoclonal enzyme-linked immunoassay kit: assay performance and feasibility for epidemiological studies. Cancer Epidemiol Biomarkers Prev (1996) 1.38
CYP2D6 genotype and the incidence of anal and vulvar cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.38
Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol (1993) 1.37
Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer (2003) 1.37
Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history. Cancer (2001) 1.33
Formaldehyde and cancers of the pharynx, sinus and nasal cavity: I. Occupational exposures. Int J Cancer (1986) 1.32
Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst (1982) 1.32
Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989. Arthritis Rheum (1991) 1.30
Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol (1996) 1.28
Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol (1999) 1.27
Detection and localization of human papillomavirus DNA in human genital condylomas by in situ hybridization with biotinylated probes. J Med Virol (1985) 1.26
Puerperal infectious morbidity: relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am J Obstet Gynecol (1980) 1.26
Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS (1993) 1.26
Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst (1994) 1.25
The frequency of breech presentation by gestational age at birth: a large population-based study. Am J Obstet Gynecol (1992) 1.24
Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol (2000) 1.23
Occurrence of breast cancer in relation to recreational exercise in women age 50-64 years. Epidemiology (1996) 1.23
Mortality in women following hip fracture. J Chronic Dis (1983) 1.21
Events of reproductive life and the incidence of epithelial ovarian cancer. Am J Epidemiol (1983) 1.20
A case-control study of maternal smoking and congenital malformations. Paediatr Perinat Epidemiol (1990) 1.20
Tubal infertility in relation to prior induced abortion. Fertil Steril (1985) 1.20
Appendectomy and the risk of tubal infertility. N Engl J Med (1986) 1.19
Formaldehyde and cancers of the pharynx, sinus and nasal cavity: II. Residential exposures. Int J Cancer (1986) 1.19
Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst (1981) 1.19
Maternal factors and breast cancer risk among young women. Paediatr Perinat Epidemiol (1998) 1.18
Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res (1987) 1.17
Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer (1999) 1.17
Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol (1992) 1.16
Human papillomavirus infection and anal cancer. Int J Cancer (1989) 1.16
Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol (1989) 1.16
Maternal cigarette smoking and the risk of tubal pregnancy. Am J Epidemiol (1991) 1.15
Vaginal douching as a potential risk factor for tubal ectopic pregnancy. Am J Obstet Gynecol (1985) 1.14
Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biomarkers Prev (2001) 1.14
Relation between obesity and breast cancer in young women. Am J Epidemiol (1999) 1.14
Recreational physical activity and breast cancer risk among women under age 45 years. Am J Epidemiol (1998) 1.13
Fetal death and maternal occupation. An analysis of birth records in the State of Washington. J Occup Med (1984) 1.13
Birth weight and smoking during pregnancy--effect modification by maternal age. Am J Epidemiol (1994) 1.12
Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA (1983) 1.12